@misc{indiciaef57ffc3a6be8,
  title = {Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers},
  author = {Komurov, K. and Singh, N. and Privette-Vinnedge, L.},
  year = {2021},
  doi = {10.1101/2021.08.18.456887},
  url = {https://www.biorxiv.org/content/10.1101/2021.08.18.456887v1},
  note = {Source identifier: 10.1101/2021.08.18.456887}
}